Category: Pharmaceutical

Categories
Pharmaceutical

Oncological Treatment Centers to Boost the use of Radiotherapy Devices – Fact.MR Survey

250 Pages Radiotherapy Devices Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales to Radiotherapy Devices to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Radiotherapy Devices market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=77

Market Snapshot

The global radiotherapy devices market reached a valuation of around US$ 5 Bn in 2020, which amounts to close to 4% share of the overall oncology devices market. Sales of radiotherapy equipment are slated to accelerate at a CAGR of 7% to top US$ 10 Bn by 2031. Demand for linear accelerator devices, which holds the highest market share, is set to increase at a CAGR of 6% across the assessment period of 2021 to 2031.

Radiotherapy Devices Market Size in 2020 US$ 5 Bn
Sales Forecast for Radiotherapy Devices by 2031 US$ 10 Bn
Global Market Growth Rate (2021 to 2031) 7% CAGR
Share of Top 5 Radiotherapy Device Manufacturers 50%

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Radiotherapy Devices market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Radiotherapy Devices

Radiotherapy devices market regional analysis by Fact.MR

The report offers actionable and valuable market insights of Radiotherapy Devices. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Radiotherapy Devices Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Radiotherapy Devices, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Radiotherapy Devices Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=77

Key Market Segments in Radiotherapy Devices Industry Research

·                   Product Type

  • External Beam Radiotherapy Systems
  • Linear Accelerator Devices
    • Conventional Linear Accelerators (LINAC)
  • Conventional Cobalt-60 Teletherapy units
  • Electron-emitting High-energy Linear Accelerators
  • Advanced Stereotactic Radiotherapy Units
    • CyberKnife
    • Gamma Knife
    • TomoTherapy
  • Proton Therapy Devices
    • Cyclotron
    • Synchrotron
    • Synchrocyclotron
  • Internal Beam Radiotherapy Systems
    • Brachytherapy
    • Electronic Brachytherapy Products
    • Brachytherapy Afterloaders
  • Radiotherapy Software
    • Radiotherapy Treatment Planning Software
    • Radiotherapy Dosage Planning Software
    • Radiotherapy Patient Positioning Software
    • Radiotherapy Image Guiding Software

·                   Procedure

  • External Beam Radiotherapy
    • Image-guided Radiotherapy
    • Intensity-modulated Radiotherapy
    • Stereotactic Therapy
    • 3D conformal radiotherapy
  • Internal Beam Brachytherapy
    • High-dose-rate Brachytherapy
    • Low-dose-rate Brachytherapy
    • Pulsed-dose-rate Brachytherapy
  • Systemic Radiotherapy
  • Intraoperative Radiotherapy
  • IORT Systems
  • Intravenous Radiotherapy
  • Oral Radiotherapy
  • Instillation Radiotherapy

·                   Application

  • Radiotherapy Devices for Cancer Treatment
  • Advanced Radiotherapy Systems for Cancer Treatment
  • External Beam Radiotherapy for Prostate Cancer
  • External Beam Radiotherapy for Breast Cancer
  • External Beam Radiotherapy for Lung Cancer
  • External Beam Radiotherapy for Head and Neck Cancer
  • External Beam Radiotherapy for Colorectal Cancer
  • Internal Beam Radiotherapy for Prostate Cancer
  • Internal Beam Radiotherapy for Gynecological Cancer
  • Internal Beam Radiotherapy for Breast Cancer
  • Internal Beam Radiotherapy for Cervical Cancer
  • Internal Beam Radiotherapy for Penile Cancer

·                   End User

  • Use of Radiotherapy Devices in Hospitals
  • Use of Radiotherapy Devices in Independent Radiotherapy Centers

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/77

Competitive Landscape

The radiation therapy devices market is highly competitive and consists of a few leading manufacturers of radiotherapy devices.

  • In June 2020, Accuray announced the Cyberknife S7 system, which enables improved accuracy and real-time artificial intelligence powered motion tracking. This radiotherapy device is used to deliver treatments such as stereotactic radiosurgery, and stereotactic body radiation therapy. Cyberknife S7 system is a robotic, non-invasive radiation therapy device that can be used to treat malignant and benign tumours as well as neurologic problems across the body.

Key Projections on the Global Radiotherapy Devices Market:

  1. In 2017, global sales of linear accelerator devices is expected to procure nearly half of global radiotherapy devices market value. The sales of linear accelerators for radiotherapy is expected to gain steadfast traction, procuring an annual growth of more than US$ 280 Mn from 2017 to 2022.
  2. With soaring incidence of cancers across European countries, the healthcare infrastructure in this region is expected to remain lucrative for adoption of effective cancer therapies such as radiotherapy. The demand for radiotherapy devices is expected to gain traction in Europe owing to its advantage over other cancer therapeutic devices in terms of controlling the growth of the malignant tumors. Moreover, cancer patients are likely to remain more inclined towards radiotherapy devices that limit the hospital stay duration. According to the report, Europe will remain the largest market for radiotherapy devices throughout the forecast period.
  3. In North America, changing lifestyles of consumers and penetration of urban cultures is fuelling the incidence of pancreatic cancer. Radiotherapy devices are expected to remain of great use in treatment of pancreatic cancer and borderline resectable cancer. The radiotherapy devices market in North America is expected to witness robust gains throughout the forecast period.
  4. Manufacturers of radiotherapy devices are expected to view the Asia-Pacific excluding Japan (APEJ) region as lucrative for setting up production units. Favorable industrial regulations, low wages and high resource availability is expected to drive the growth of radiotherapy devices market in the APEJ region. The report predicts that the APEJ radiotherapy devices market is expected to grow at the fastest pace, reflecting a stellar CAGR of 11.5% through 2022.
  5. Towards the end of 2022, hospitals will emerge to be the largest end-users of radiotherapy devices. The demand for radiotherapy devices in oncological treatment centers is also anticipated to gain traction, procuring over one-fourth share on global market values throughout the forecast period.

The report has profiled leading manufacturers of radiotherapy devices which are expected to remain active in the expansion of global market, and these include Varian Medical Systems, RaySearch Laboratories AB, Theragenics Corp, Toshiba Medical Systems Corporation, Elekta AB, Accuray, Inc., IsoRay, Inc., GE Healthcare, Vision RT Ltd., C.R. Bard, Inc., Koninklijke Philips N.V., Siemens AG, IBA Ion Beam Applications SA, Eckert & Ziegler Bebig, Mitsubishi Electric Corporation, Shinva Medical Instrument Company Limited, Neusoft Medical Systems Co., Ltd. and AngioDynamics, Inc.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Radiotherapy Devices Category and segment level analysis:Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Radiotherapy Devices Historical volume analysis: The report provides a comparison of Radiotherapy Devices’s historical sales and projected sales performance for 2021-2031.
  • Radiotherapy Devices Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Radiotherapy Devices market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Radiotherapy Devices Consumption by demographics: The report investigates consumer behavior affecting Radiotherapy Devices demand outlook for the assessment period. Effect of their keenness for digital trends on Radiotherapy Devices market is carefully analyzed
  • Post COVID consumer spending on Radiotherapy Devices: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Radiotherapy Devices market growth.

More Valuable Insights on Radiotherapy Devices Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Radiotherapy Devices, Sales and Demand of Radiotherapy Devices, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Latest Advances in Kidney Cancer Diagnostics Pushing Uptake by 2x through 2031 – Fact.MR Study

250 Pages Kidney Cancer Diagnostics Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Kidney Cancer Diagnostics to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Kidney Cancer Diagnostics market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=56

Market Snapshot

As per latest industry analysis published by Fact.MR, the global kidney cancer diagnostics market reached a valuation of around US$ 600 Mn in 2020, and is slated to accelerate at a CAGR of 7% through 2031. Demand for immunohistochemistry tests is set to increase at a CAGR of 6% across the assessment period of 2021 to 2031. Overall, the worldwide kidney cancer diagnostics market is set to top US$ 1.2 Bn by 2031.

Market Size Value in 2020 US$ 600 Mn
Market Forecast Value for 2031 US$ 1.2 Bn
Global Growth Rate CAGR 7%
Share of Top 5 Companies 50%

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Kidney Cancer Diagnostics market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Kidney Cancer Diagnostics

Kidney cancer diagnostics market regional analysis by Fact.MR

The report offers actionable and valuable market insights of Kidney Cancer Diagnostics. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Kidney Cancer Diagnostics Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=56

Key Segments Covered in Kidney Cancer Diagnostics Industry Research

  • Test

    • Immunohistochemistry Test for Kidney Cancer Diagnostics
    • Complete Blood Count Test for Kidney Cancer Diagnostics
    • Urine Test for Kidney Cancer Diagnostics
    • Blood Chemistry Test for Kidney Cancer Diagnostics

  • Indication

    • Renal Cell Carcinoma Kidney Cancer
    • Transitional Cell Carcinoma Kidney Cancer
    • Kidney Sarcoma Kidney Cancer
    • Wilms Tumor Kidney Cancer
    • Kidney Lymphoma Kidney Cancer

  • End User

    • Hospital-associated Labs for Kidney Cancer Diagnostics
    • Independent Diagnostic Laboratories for Kidney Cancer Diagnostics
    • Cancer Research Institutes for Kidney Cancer Diagnostics
    • Others
      • Metastatic Kidney Cancer Therapy
      • Nephrectomy Therapy for Kidney Cancer
      • Cytokine-based Treatment for Kidney Cancer
      • Diagnostic Laboratories for Kidney Cancer
      • Diagnostics Test for Kidney Cancer

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/56

Competitive Landscape

There are a large number of companies that are making significant contribution to kidney cancer treatment market growth.

Manufacturers of kidney cancer diagnosis instruments are partnering with regional health ministries and medical administrators to assess the therapeutic diagnosis’s impact on kidney cancer patients. Medical organizations as well as leaders in the global pharmaceuticals industry are doubling down on the development of advanced kidney cancer diagnoses.

9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market

  1. Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
  2. Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
  3. Cancer research institutes will register the fastest expansion in the market during the forecast period.
  4. Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
  5. Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
  6. Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
  7. North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
  8. Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
  9. Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Kidney Cancer Diagnostics Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Kidney Cancer Diagnostics Historical volume analysis: The report provides a comparison of Kidney Cancer Diagnostics’s historical sales and projected sales performance for 2021-2031.
  • Kidney Cancer Diagnostics Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Kidney Cancer Diagnostics market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Kidney Cancer Diagnostics Consumption by demographics: The report investigates consumer behavior affecting Kidney Cancer Diagnostics demand outlook for the assessment period. Effect of their keenness for digital trends on Kidney Cancer Diagnostics market is carefully analyzed
  • Post COVID consumer spending on Kidney Cancer Diagnostics: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Kidney Cancer Diagnostics market growth.

More Valuable Insights on Kidney Cancer Diagnostics Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Kidney Cancer Diagnostics, Sales and Demand of Kidney Cancer Diagnostics, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Sales of Bone Growth Stimulators Market to Bring in US$ 1.91 Bn Revenues By 2031 End

250 Pages Bone Growth Stimulator Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Bone Growth Stimulator to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Bone Growth Stimulator market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=54

Market Snapshot

According to Fact.MR’s most recent study, the bone growth stimulator market was nearly worth US$ 1.8 Bn in 2020 and is anticipated to expand 1.6x over the forecast period, anticipated to reach a valuation of US$ 3 Bn by 2031. In the short-run, bone growth stimulators revenue is likely to top US$ 1.9 Bn by 2022.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Bone Growth Stimulator market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Bone Growth Stimulator

The report offers actionable and valuable market insights of Bone Growth Stimulator. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Bone Growth Stimulator Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=54

Key Segments Covered

  • Product

    • Bone Growth Stimulation Devices
    • Platelet-Rich Plasma Bone Growth Stimulators
    • Bone Morphogenetic Protein Stimulators

  • End User

    • BGS for Hospitals & Clinics
    • BGS for Home Care
    • BGS for Academic & Research Institutes and CROS
    • BGS for Other End Users

  • Application

    • BGS for Delayed Union & Nonunion Bone Fractures
    • BGS for Spinal Fusion Surgeries
    • BGS for Oral and Maxillofacial Surgeries
    • BGS for Other Applications

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/54

Competitive Landscape

The bone growth stimulators market is highly concentrated, with a large number of worldwide competitors. With the increasing prevalence of orthopedic disorders and technology developments, a few small to mid-sized firms are also breaking into the industry.

  • In December 2020, Arthrex Inc. launched of the SwiveLock® ACL Repair Kit. This kit is designed as a less-invasive treatment method for certain types of anterior cruciate ligament. It is the first and only FDA-cleared kit for ACL tears.
  • In November 2020, Stryker Corporation completed the acquisition of Wright Medical Group N.V, a global medical device company focused on extremities and biologics, reinforcing its position in trauma and extremities treatment domains.

Key Forecast Highlights

  1. According to the report, bone growth stimulation devices will account for nearly 56% share on global bone growth stimulator revenues in 2017. Platelet-rich plasmas, on the other hand, will be observed as promising product segment, revenues from which are expected to showcase robust growth at 6.2% CAGR. By the end of 2022, a little over US$ 450 Mn worth of platelet-rich plasmas will be sold in the global market for bone growth stimulators.
  2. In the view of poor road infrastructure and inferior healthcare facilities existing in the Asia-Pacific excluding Japan (APEJ) region, the demand for bone growth stimulators is expected to gain grounds. These factors are boosting the incidence of spinal fractures in this region, compelling doctors towards adoption of bone growth simulation therapy. Moreover, manufacturers of bone growth stimulators are expected to benefit from low wage costs and high resource availability by setting up their manufacturing units across APEJ region. By the end of 2022, over US$ 225 Mn worth of bone growth stimulators will be sold across the APEJ market.
  3. North America is expected to remain the largest market for bone growth stimulator. The report predicts that high healthcare spending implemented in Canada and the US will urge manufacturers towards developing advanced bone growth stimulators. Meanwhile, revenues amassed from sales of bone growth stimulators in Europe will contribute US$ 600 Mn in revenues by the end of 2022. Towards the end of forecast period, North America’s bone growth stimulator market is likely to soar at a CAGR of 6.2%.
  4. Application of bone growth stimulators in delayed union & non-union bone fracture treatments is expected to gain traction, reflecting a revenue growth at 5.7% CAGR. Spinal fusion surgeries will account for nearly 25% of the global bone growth stimulator sales in 2017, while their application in oral and maxillofacial surgeries will procure around US$ 250 Mn in global revenues.
  5. Hospitals and clinics are expected to remain largest end-users of bone growth stimulator throughout the forecast period. With more than 43% share, over US$ 800 Mn worth of bone growth stimulators will be sold in hospitals & clinics across the globe by 2022-end. Home care end-use of bone growth stimulator, on the other hand, is expected to create an incremental opportunity of more than US$ 100 Mn by 2022 over 2017.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Bone Growth Stimulator Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Bone Growth Stimulator Historical volume analysis: The report provides a comparison of Bone Growth Stimulator’s historical sales and projected sales performance for 2021-2031.
  • Bone Growth Stimulator Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Bone Growth Stimulator market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Bone Growth Stimulator Consumption by demographics: The report investigates consumer behavior affecting Bone Growth Stimulator demand outlook for the assessment period. Effect of their keenness for digital trends on Bone Growth Stimulator market is carefully analyzed
  • Post COVID consumer spending on Bone Growth Stimulator: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Bone Growth Stimulator market growth.

More Valuable Insights on Bone Growth Stimulator Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Bone Growth Stimulator, Sales and Demand of Bone Growth Stimulator, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

The Increasing Demand For Drug Delivery Is Expected To Drive The Growth Of The Biologic Injectors Market

Biologic injectors are the injecting devices used to deliver drugs and other substances for biological purposes. Biological products such as drugs, growth hormones, antibodies and other complex biological molecules are administered into the body of an organism through biologic injectors. Biologic injectors are basically used for the treatment of various diseases.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=2288

Biologic Injectors Market: Segmentation

Tentatively, the global biologic injectors market can be segmented on the basis of treatment, indication, distribution channel and geography.

Based on application, the global biologic injectors market has been segmented as:

  • Oncology
  • Cardiology
  • Autoimmune
  • Pain management
  • Others

Based on distribution channel, the global biologic injectors market has been segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

Get Request for Report Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2288

Biologic Injectors Market: Market Participants

The global market for biologic injectors is highly fragmented. Examples of some of the key players operating in the global biologic injectors market are

  • Roche
  • Abbott
  • Schott
  • Nipro
  • Ompi
  • Becton and Dickinson & Co.
  • Bayer AG
  • Pfizer, Inc.
  • Bristol-Myer Squibb
  • Novartis International AG
  • Novartis AG
  • Others.
Biologic Injectors Market: Overview

The global market for biologic injectors is expected to witness moderate growth over the forecast period. Biologic injectors find a vast range of applications such as oncology, cardiology, autoimmune disorders and many others. Based on distribution channel, the biologic injectors market has been segmented into hospitals, pharmacies and various other drug stores. Drug delivery is one of the main applications where biologic injectors play an important role.

Biologic Injectors Market: Regional Outlook

On the basis of geography, the global biologic injectors market has been segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be the dominant region in the global biologic injectors market, owing to advancements in healthcare technologies in the region. Europe is expected to hold the second large share in the global biologic injectors market throughout the forecast period.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Preimplantation Genetic Screening Market is Projected to Grow at Nearly 9% CAGR During Forecast period 2021-2031

250 Pages Preimplantation Genetic Screening Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Preimplantation Genetic Screening to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Preimplantation Genetic Screening market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=292

Market Snapshot

According to Fact.MR, the market for preimplantation genetic testing is likely to register an impressive valuation by 2031. Increasing prevalence of genetic disorders is broadening growth prospects. The market is projected to grow at nearly 9% CAGR through 2031.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Preimplantation Genetic Screening market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Preimplantation Genetic Screening

The report offers actionable and valuable market insights of Preimplantation Genetic Screening. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Preimplantation Genetic Screening Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Preimplantation Genetic Screening, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Preimplantation Genetic Screening Market.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=292

Key Segments Covered

  • Test Type

    • Preimplantation Genetic Diagnostics
    • Preimplantation Genetic Screening

  • End User

    • Preimplantation Genetic Testing in Hospitals
    • Preimplantation Genetic Testing in Diagnostic Labs
    • Preimplantation Genetic Testing in Research & Academic Institutions
    • Preimplantation Genetic Testing in Specialized Clinics
    • Preimplantation Genetic Testing by Other End Users

  • Application

    • Preimplantation Genetic Testing for Embryo HLA Typing for Stem Cell Therapy
    • Preimplantation Genetic Testing for IVF Prognosis
    • Preimplantation Genetic Testing for Late-Onset Genetic Disorders
    • Preimplantation Genetic Testing for Inherited Genetic Diseases
    • Preimplantation Genetic Testing for Other Applications

  • Technology

    • NGS-based Preimplantation Genetic Testing
    • PCR-based Preimplantation Genetic Testing
    • FISH-based Preimplantation Genetic Testing
    • CGH-based Preimplantation Genetic Testing
    • SNP-based Preimplantation Genetic Testing
Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/292

Competitive Landscape

Preimplantation genetic testing market is a highly consolidated market in which a small group of players accounts for near half of the global sales.

In May 2021, United Airlines and Abbott Laboratories announced a collaboration to use Abbott’s BinaxNOW™ COVID-19 Home Test and Abbott’s NAVICA app to help make the international travel experience more seamless.

The CDC guidelines permit travelers to self-administer a rapid antigen test under the real-time supervision of a telehealth service and use the verified negative test result to board an international flight to the U.S. if they test negative.

6 Forecast Highlights on Global Preimplantation Genetic Testing Market

  • North America is likely to emerge as the biggest market in the global preimplantation genetic testing. North America preimplantation genetic testing market is projected to surpass US$ 200 million by the end of 2022. Increasing adoption of innovative technologies and rising awareness about preimplantation genetic testing to avoid various birth defects among babies are some of the factors fueling the market growth in the region.
  • Europe is expected to be the second most lucrative market for preimplantation genetic testing. Owing to the presence of various healthcare institutions and hospitals providing preimplantation genetic testing and high awareness due to the various initiatives by the government is driving the growth of preimplantation genetic testing in Europe.
  • A genetic screening test is likely to emerge as one of the most preferred test types in the global preimplantation genetic testing market. By the end of 2022, Genetic screening is projected to surpass US$ 300 million revenue.
  • Specialized clinics are likely to be the largest users of the preimplantation genetic testing. By the end of 2017, specialized clinics are projected to account for nearly two-fifth of the revenue share on the global revenue.
  • Preimplantation genetic testing is likely to find the largest application in embryo HLA typing for stem cell therapy. Accounting for more than two-fifth of the revenue share, embryo HLA typing for stem cell therapy is projected to bring in more than US$ 200 million revenue by 2022 end.
  • NGS is likely to emerge as the biggest technology in preimplantation genetic testing. Witnessing a strong growth during the forecast period, NGS is anticipated to create an incremental opportunity of over US$ 80 million between 2017 and 2022.

The report has also profiled leading players in the global market for preimplantation genetic testing, which will remain active through 2022. These include companies such as Abbott Laboratories, Agilent Technologies Inc., CooperSurgical Inc., Illumina, Inc., Oxford Gene Technology IP, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., Natera, Inc., CombiMatrix Corporation, Rubicon Genomics, Inc., and Genea Limited.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Preimplantation Genetic Screening Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Preimplantation Genetic Screening Historical volume analysis: The report provides a comparison of Preimplantation Genetic Screening’s historical sales and projected sales performance for 2021-2031.
  • Preimplantation Genetic Screening Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Preimplantation Genetic Screening market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Preimplantation Genetic Screening Consumption by demographics: The report investigates consumer behavior affecting Preimplantation Genetic Screening demand outlook for the assessment period. Effect of their keenness for digital trends on Preimplantation Genetic Screening market is carefully analyzed
  • Post COVID consumer spending on Preimplantation Genetic Screening: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Preimplantation Genetic Screening market growth.

More Valuable Insights on Preimplantation Genetic Screening Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Preimplantation Genetic Screening, Sales and Demand of Preimplantation Genetic Screening, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Growing Prevalence Of Back Pain & Cancer Is Expected To Drive The Neuro Ablation Devices Market

Neuro ablation devices are medical devices that are applied to iatrogenic Peripheral Nerve Injury (PNI). A peripheral nerve is composed of axon, myelin, endoneurium, fascicle, perineurium and epineurium. The individual myelinated axons and groups of unmyelinated axons are usually surrounded by the endoneurium. Currently available neuro ablation devices focus on precise and target-oriented denervation. Recurrence of pain after a short period is always a problem in pain practice.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=2283

Neuro Ablation Devices Market: Segmentation

The global neuro ablation devices market has been segmented on the basis of product type, indication, end users and geography.

Based on product type, the global neuro ablation devices market is segmented as:

  • Alcohol Neurolysis
  • Radiofrequency Ablation (RFA)
    • Thermal RFA
    • Pulsed RFA

Based on indication, the global neuro ablation devices market is segmented as:

  • Spinal Joint pain
  • Visceral Cancer Pain
  • Axial Back/neck pain
  • Radicular neck/back pain
  • Trigeminal neuralgia
  • Occipital neuralgia
  • Others

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2283

Neuro Ablation Devices Market: Key Players

The global market for neuro ablation devices is highly fragmented. Some of the key players operating in the global neuro ablation devices market are

  • Medtronic Plc
  • Biosense Webster Inc. (Sub. Of Johnson & Johnson)
  • St. Jude Medical
  • Boston Scientific Corporation
  • Angiodynamics Inc.
  • Articulture Inc.
  • Conmed Corporation
  • Olympus Corporation
  • Smith & Nephew

Neuro Ablation Devices Market: Regional Outlook

Geographically, the global neuro ablation devices market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), CSI & Russia, Japan and the Middle East and Africa (MEA). North America is expected to be the dominant market in the global neuro ablation devices market owing to the availability of technologically advanced products, high awareness among the general public and increasing healthcare spending. The neuro ablation devices market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increased R&D spending and advancements in technology.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Urodynamic Devices Market in APEJ is Expected to Register the Fastest Expansion through 2031

250 Pages Urodynamic Devices Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of Urodynamic Devices to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Urodynamic Devices market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=168

An impressive expansion is estimated for the global urodynamic devices market, according to a new report by Fact.MR, for the forecast period 2017 to 2022. A number of technological advancements have been witnessed in urodynamic devices, which include intravesical prostatic protrusion, condom catheter, ultrasound video urodynamic, and penile cuff. These advancements in technology will fuel adoption of urodynamic devices worldwide.

Moreover, other factors such as continuous product approvals, rising proliferation of testing center networks, and soaring provision of medical reimbursements related to urological preliminary tests are further poised to propel growth of the market. Revenues from the global urodynamic devices market will reach US$ 265 Mn in revenues by the end of the forecast period.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Urodynamic Devices market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Urodynamic Devices

The report offers actionable and valuable market insights of Urodynamic Devices. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Urodynamic Devices Market across various industries and regions

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=168

Market Taxonomy

Device Type
  • Uroflowmetry
  • Ambulatory Urodynamic Devices
  • Cystometer
  • Video Urodynamic Devices
  • Electromyography
  • Urodynamic Catheters
  • Urodynamic Pumps And Transducer Sets
End User
  • Hospitals
  • ASCs
  • Urology Clinics
  • Others

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)


Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/168

Competition Tracking

Key players participating in the global urodynamic devices market include

  • Albyn Medical Ltd.
  • Boston Scientific Corporation
  • Medica SpA
  • Neomedix Systems Pty. Ltd.
  • Dantec Dynamics A/S
  • CooperSurgical Inc.
  • LABORIE
  • Verathon Inc.
  • Best Medical International Inc.

Increasing Initiatives to Spread Awareness about Urological Disorders to Boost the Market Growth

The World Health Organization (WHO) has estimated over 300,000 patients to be affected with bladder cancer annually around the world. The National Association of Incontinence estimates roughly 200 Mn population across the globe to be suffering from urinary incontinence every year. Incidences such as these have increased demand for urodynamic devices, along with the rise in clinical urgency. Numerous healthcare initiatives have been creating awareness about urological disorders, coupled with availability of diagnostics and treatment for urological problems. Some initiatives among these include “Continence Awareness Week” undertaken by the U.K.’s Continence Foundation, and Japan’s “Let’s Talk and Think About Continence”. These initiatives are depriving people of social stigma, encouraging them to consult physicians. The aforementioned factors will boost growth of the global urodynamic devices market in the upcoming years.

Uroflowmetry Urodynamic Devices to Remain Sought-after in the Market

Uroflowmetry urodynamic devices will continue to be sought-after among physicians, and revenues from sales of uroflowmetry urodynamic devices will hold more than one-fourth share on global revenues throughout the forecast period. Significant use of uroflowmetry to diagnose prostate cancer, benign prostatic hypertrophy, urinary blockage, bladder cancer, neurogenic bladder, and bladder dysfunction, are contributing to demand for uroflowmetry urodynamic devices in hospitals and urology clinics globally. In addition, sales of urodynamic catheters are projected to register the fastest expansion in the market through 2022.

Urology clinics will continue to be the fastest growing end-users of urodynamic devices in the global market. Hospitals are estimated to remain the largest end-users of urodynamic devices over the forecast period. North America will account for the largest share of the revenues from urodynamic devices sales in hospitals. Urodynamic devices sales in hospitals are anticipated to account for more than US$ 150 Mn revenues by 2022-end.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • Urodynamic Devices Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Urodynamic Devices Historical volume analysis: The report provides a comparison of Urodynamic Devices’s historical sales and projected sales performance for 2021-2031.
  • Urodynamic Devices Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Urodynamic Devices market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Urodynamic Devices Consumption by demographics: The report investigates consumer behavior affecting Urodynamic Devices demand outlook for the assessment period. Effect of their keenness for digital trends on Urodynamic Devices market is carefully analyzed
  • Post COVID consumer spending on Urodynamic Devices: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Urodynamic Devices market growth.

More Valuable Insights on Urodynamic Devices Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Urodynamic Devices, Sales and Demand of Urodynamic Devices, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

 

Categories
Pharmaceutical

Increasing and Consistent Investments For Healthcare Infrastructural Development is Key for Driving Neuralgia Treatment Market

Neuralgia is an abnormal symptom with effects like sharp, burning, and mostly severe pain, due to an irritated or damaged nerve. The causative nerve may be from anywhere in the body, The damage caused by the nerve is associated with several factors like aging, cardiovascular diseases, diabetes, multiple sclerosis, shingles infection, and more. Therefore, Neuralgia Treatment for the pain is directed towards its roots or its site of origin.

Request For Sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=2282

Neuralgias Market: Segmentation

Tentatively, the global Neuralgia Treatment market can be segmented on the basis of treatment type, distribution channel, and geography.

Based on treatment type, the global Neuralgia Treatment market is segmented as:

  • Medications for Neuralgia Treatment
    • Anticonvulsant Medicines
      • Carbamazepine
      • Oxcarbazepine
      • Topiramate
      • Gabapentin
      • Pregabalin
      • Clonazepam
      • Phenytoin
      • Lamotrigine
      • Valproic acid
    • Tricyclic Antidepressants
      • Amitriptyline
      • Nortriptyline
  • Surgeries for Neuralgia Treatment
    • Balloon Compression
    • Glycerol Injection
    • Radiofrequency Thermal Lesioning
    • Stereotactic Radiosurgery
    • Microvascular Decompression
  • Complementary Approaches for Neuralgia Treatment (in combination with medications)

Based on distribution channel, the global Neuralgia Treatment market is segmented as:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

Get Detailed Table of Content of this Market –  https://www.factmr.com/connectus/sample?flag=T&rep_id=2282

Neuralgia Treatment Market: Key Players

Some of the key players operating in the global neuralgias market are

  • Allergan Plc
  • Merz Pharma GmbH & Co.
  • Biogen, Inc.
  • Merz Pharma GmbH & Co.
  • Abbott Laboratories
  • Trigemina Inc.
  • Pfizer Inc.
  • Novartis
  • GlaxoSmithKline Plc. F, Lupin
  • Others.

Neuralgia Treatment Market: Regional Outlook

Globally, North America, which includes the U.S., is expected to majorly contribute to the Neuralgia Treatment market. Aggressive healthcare investments and increasing awareness among people about Neuralgia Treatments will contribute to the growth of this region’s market. Asia Pacific is anticipated to have the second-largest market share in the Neuralgia Treatment market, primarily due to the largest geriatric population in the world present in China, India, and Japan.

In addition, improved living conditions and better health care initiatives by governing bodies will also fuel the growth of the Neuralgia Treatment market. Europe, with its rising prevalence of chronic pain disorders in its developed and developing countries, will be the third-largest contributor to the Neuralgia Treatment market. Latin America and the Middle East & Africa are expected to show considerable growth in the neuralgias market in the near future, thanks to some of the developed and emerging economies such as GCC countries, Brazil, and Mexico, which are evolving with good healthcare governance.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

OTC Cough, Cold, and Allergy Medicine Market Revenue in the APEJ Region is Expected to Grow 1.3X by 2031 End

250 Pages OTC Cough, Cold, and Allergy Medicine Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

According to Fact MR’s recent market research, sales of OTC Cough, Cold, and Allergy Medicine to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, OTC Cough, Cold, and Allergy Medicine market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=71

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth.

Digital Transformation in Healthcare Presenting Opportunities for OTC Cough, Cold, and Allergy Medicine Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the OTC Cough, Cold, and Allergy Medicine market.

OTC cough cold and allergy medicine market regional analysis by Fact.MR

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=71

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of OTC Cough, Cold, and Allergy Medicine market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of OTC Cough, Cold, and Allergy Medicine

The report offers actionable and valuable market insights of OTC Cough, Cold, and Allergy Medicine. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of OTC Cough, Cold, and Allergy Medicine Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of OTC Cough, Cold, and Allergy Medicine, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of OTC Cough, Cold, and Allergy Medicine Market.

Market Snapshot

As per latest industry analysis published by Fact.MR, the global OTC cough, cold, and allergy medicine market was valued at around US$ 35 Bn in 2020, and is expected to accelerate at a CAGR of over 5.5% through 2031. Demand for bronchodialators is set to increase at a CAGR of 5% across the assessment period of 2021 to 2031. Overall, the worldwide OTC cough, cold, and allergy medicine market is projected to expand 1.7X over the decade.

Market Size Value in 2020 US$ 35 Bn
Market Forecast Value for 2031 US$ 60 Bn
Projected Global Growth Rate (2021 to 2031) 5.5% CAGR
Share of Top 5 Companies 40%

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/71

Key Segments in OTC Cough, Cold, and Allergy Medicine Industry Research

·         Drug Type

    • OTC Antihistamine
    • OTC Expectorants
    • OTC Bronchodialators
    • OTC Antibiotics

·         OTC Channel

    • Sales of OTC Cough, Cold & Allergy Medicines via Pharmacies
    • Drug Store Sales of OTC Cough, Cold & Allergy Medicines
    • Modern Trade Sales of OTC Cough, Cold & Allergy Medicines
    • Online Sales of OTC Cough, Cold & Allergy Medicines

·         Dosage

    • OTC Cough, Cold & Allergy Medicine Capsules
    • OTC Cough, Cold & Allergy Medicine Liquid
    • OTC Cough, Cold & Allergy Medicine Tablets
    • OTC Cough, Cold & Allergy Medicine Lozenges
    • Others
      • OTC Liquid Cough, Cold & Allergy Solutions
      • OTC Liquid Cough, Cold & Allergy Drops
      • OTC Liquid Cough, Cold & Allergy Granules
      • OTC Liquid Cough, Cold & Allergy Syrup
      • OTC Liquid Cough, Cold & Allergy Pills

·         Application

    • OTC Cough, Cold & Allergy Medicines for Babies
    • OTC Cough, Cold & Allergy Medicines for Adults
    • OTC Cough, Cold & Allergy Medicines for School-age Children

Competitive Landscape

The market is hugely competitive with a number of top OTC cough, cold, and allergy medicine manufacturers. Few major players currently dominate the market in terms of revenue share.

Personalized patient care and access to complete end-to-end medical device products and services are now available from healthcare service providers and top companies in the OTC cough, cold & allergy medicine market.

Mid-size and smaller businesses, on the other hand, are expanding their market presence by introducing new products at lower prices, thanks to technological advancements and product innovation.

According to the survey data, majority of people around the world want their cough, cold, and allergy remedies to be more effective and safe. Growing consumer awareness of these products has also driven market growth.

Furthermore, increased market competition leads to the development of products with improved effectiveness and a variety of safe ingredients. Government initiatives, growing adoption of innovative products, and improved healthcare facilities are expected to fuel OTC cough, cold, and allergy medicine market growth over the decade.

Key Takeaways from Market Study

  • Global OTC cough, cold, and allergy medicine market to top US$ 60 Bn by 2031.
  • Bronchodialators projected to reach valuation of around US$ 25 Bn by 2031.
  • Antihistamine projected to record above 4% CAGR over next 10 years.
  • Market in APEJ holds share of more than 40%.
  • Market in South Korea expected to reach valuation of US$ 15 Bn by 2031.
  • Market in Australia to record 3% CAGR over forecast period of 2021- 2031.

“Increasing investments by public and government bodies in the healthcare sector, higher availability of a wide range of products, and easy access to self-administered drugs for minor allergies and illnesses are positively impacting sales of OTC cough, cold, and allergy medicines,” says a Fact.MR analyst.

Read More Trending Reports of Fact.MR-

https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/

Report Benefits & Key Questions Answered

  • OTC Cough, Cold, and Allergy Medicine Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • OTC Cough, Cold, and Allergy Medicine Historical volume analysis: The report provides a comparison of OTC Cough, Cold, and Allergy Medicine’s historical sales and projected sales performance for 2021-2031.
  • OTC Cough, Cold, and Allergy Medicine Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the OTC Cough, Cold, and Allergy Medicine market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • OTC Cough, Cold, and Allergy Medicine Consumption by demographics: The report investigates consumer behavior affecting OTC Cough, Cold, and Allergy Medicine demand outlook for the assessment period. Effect of their keenness for digital trends on OTC Cough, Cold, and Allergy Medicine market is carefully analyzed
  • Post COVID consumer spending on OTC Cough, Cold, and Allergy Medicine: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting OTC Cough, Cold, and Allergy Medicine market growth.

More Valuable Insights on OTC Cough, Cold, and Allergy Medicine Market

Fact.MR, in its new report, offers an unbiased Market Analysis of OTC Cough, Cold, and Allergy Medicine, Sales and Demand of OTC Cough, Cold, and Allergy Medicine, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Categories
Pharmaceutical

Surging Cases of Insomnia and Sleep Apnea to Accelerate Actigraphy Sensors Sales: Fact.MR

Actigraphy sensors are the devices used to evaluate physical movements of an individual with sleep disorders. Actigraphy sensors collect information by monitoring body movements during sleep. Actigraphy sensors is the small portable device that collects resulting information by tracking physical motion. Actigraphy sensor is a device which is commonly worn on the wrist, ankle, or neck of the body. The device has been developed based on the assumption that when an individual sleeps, his/her body activity reduces and that activity can be used as an indicator for identifying sleep disorders.

Request a report sample to gain comprehensive insights at-  https://www.factmr.com/connectus/sample?flag=S&rep_id=2274

Actigraphy Sensors Market: Segmentation

The global actigraphy sensors market can be segmented on the basis of product type, indication, application, and geography.

Based on product type, the global actigraphy sensors market is segmented into:

  • Watch
  • Fitbit

Based on indication, the global actigraphy sensors market is segmented into:

  • Sleep Apnea
  • Insomnia
  • Narcolepsy
  • Restless Leg Syndrome
  • Rapid Eye Movement Behavior Disorder
  • Delayed Sleep Phase Syndrome
  • Sleepwalking

Based on application, the global actigraphy sensors market is segmented into:

  • Sleep Medicine
  • Sleep Disorder
  • Circadian Rhythm Disorder
  • Daytime Activity Research

For Request for Customization –  https://www.factmr.com/connectus/sample?flag=RC&rep_id=2274

Actigraphy Sensors Market: Overview

The global market for actigraphy sensors is expected to witness high growth over the forecast period. Increasing prevalence of sleeping disorders is observed in working population with unusual timings. Innovations and adaptation of new technology are the other important factors contributing to the growth of the global actigraphy sensors market.

Actigraphy Sensors Market: Key Players

Examples of some of the key players operating in the global actigraphy sensors market are

  • Philips Respironics
  • Aetna
  • Activinsights
  • Others.

Actigraphy Sensors Market: Regional Outlook

Geographically, the actigraphy sensors market is segmented into North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan, and the Middle East & Africa (MEA). North America’s actigraphy sensors market is expected to dominate the global market followed by Europe, due to significant improvement in health awareness, assessment, and expenditure along with rapidly growing economy. However, the Asia Pacific actigraphy sensors market is also estimated to grow at a high rate over the forecast period due to expansion of healthcare structure and increase in number of patient population.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/demand-for-tricuspid-valve-repair-rising-as-congenital-and-rheumatoid-heart-disease-cases-increase-fact-mr/ 

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis 2016 – 2020 and Opportunity Assessment 2021 – 2031

About Us:

Fact.MR research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analysed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com